Ameritas Advisory Services, LLC Bristol Myers Squibb CO Transaction History
Ameritas Advisory Services, LLC
- $2.58 Billion
- Q2 2024
A detailed history of Ameritas Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 15,235 shares of BMY stock, worth $810,349. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,235
Previous 17,264
11.75%
Holding current value
$810,349
Previous $936,000
32.48%
% of portfolio
0.02%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...